How to make open innovation work
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

How to make open innovation work

No fewer than four reports addressing open innovation have landed in my Inbox in the past couple of weeks. Is this just a coincidence, or is there a trend?

future Is Open

The four reports are:

The Future is Open: 2015 State of Innovation (Thomson Reuters) – looking at how companies such as Samsung and Toyota have embraced open innovation (right)

Innovation without borders: Six best practices to improve innovation success rates (Evalueserve) – including case studies of companies such as P&G, Clorox and Danone (below left)

Executing an open innovation model (Deloitte) – focusing on the biopharma industry

Who Owns the World’s Patents? (ORoPO) – concluding that lack of transparency about patent ownership impedes IP licensing (below right)


The Thomson Reuters report argues that there is indeed a trend towards collaboration, driven by the pace of innovation globally: “By leveraging that which has been done before and partnering with organizations that may solve for one aspect of an invention, companies are able to go to market more quickly and meet consumer demand for faster innovation time cycles.” For example, about 130 of every 10,000 patents filed by are done jointly with an academic institution, and it ranks among the top 25 innovators in nine of the 12 industries analysed.

But open innovation is not new, of course, and the Evalueserve report identifies best practices based on experiences of companies such as Unilever and Nestlé. These include setting up dedicated teams, building innovation networks and developing an organisational culture to support innovation. P&G’s Connect & Develop programme is an oft-cited open innovation success story: innovation from external sources jumped from 10% to more than 50% from 2001 to 2008, and gave us products such as Tide Pods and Crest White Strips.

Deloitte’s report argues that biopharma companies, where a “closed, traditional model” accounts for about 80% of products, might learn from other industries where collaboration is more common. In fact, its analysis found that open innovation products enjoyed a higher success rate than closed-model products – but mentioned concerns about IP rights as one brake on further take-up. “For biopharma companies, OI seems to be the way forward, as it appears to be a more cost- and time-effective way to bring drugs to market. In fact, several key trends will likely continue to drive the adoption of OI, especially at the most open end of the spectrum,” writes the report’s author, Ralph Marcello.


So is open innovation now set to soar across diverse industries? The final report mentioned above provides a note of caution: “Given the historic trend in licensing, is that a great deal more value could be realised, if inefficiencies and uncertainties in the system could be eliminated – by solving the problem of patent ownership data accuracy.” ORoPO is aiming to tackle this perceived problem by creating a global database of patent ownership, and already has some large IP owners on board.

One point that comes across in all of these reports is that effective open innovation requires engagement across an organisation, including the senior management, research, marketing and of course legal teams. Given the role played by patents and other IP rights, the involvement of the IP team is crucial, but are IP advisers (both in-house and outside) willing and able to make open innovation work, or are they still more comfortable following more traditional closed models? And, assuming your organisation wants to promote open innovation, what role should IP advisers play in implementing and developing it?

These are some questions that we will be coming back to over the next few months, and look forward to hearing readers’ views.

more from across site and ros bottom lb

More from across our site

Meet the esteemed judges who are assessing the first-ever Social Impact Awards
Lawyers debate whether the Supreme Court’s ruling helps maintain confidence in the trademark system
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
The group of lawyers, which includes seven IP partners, say they were impressed by ArentFox Schiff's wide-reaching experience
Andy Sherman, general counsel at Dolby Laboratories, says the company will continue to make GE Licensing’s patents available through existing pools
CMS, which represents Nestlé, had been told to respond to a cancellation action by February 12 but filed its response a day later
Keith Bergelt, CEO of the Open Invention Network, explains why AI technologies were not part of an update to its cross-licensing project
Kirkland & Ellis partners explain how they secured the dismissal of a patent case in which the other side had lied under oath
Managing IP understands the association had been considering other options, including Madrid or Vienna, after concerns were raised over Dubai’s positions on various rights
Chris Marando tells Managing IP that he's excited to work on PTAB matters at Perkins Coie, which recently hired another lawyer from his former firm
Gift this article